Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [916]
News [2620]
Articles [112]
Editorials [3]
Conferences [85]
elearning [27]
Prompt recognition and treatment found effective for lung disease in patients who received new drug for advanced cancer
Prompt recognition and treatment found effective for lung disease in patients who received new drug for advanced...
WCLC 2022: Chinese researchers develop lung cancer risk prediction nomogram for female non - smokers
WCLC 2022: Chinese researchers develop lung cancer risk prediction nomogram for female non - smokers
WCLC 2022: Association between KRAS/STK11/KEAP1 mutations and outcomes in POSEIDON: Durvalumab ± tremelimumab + chemotherapy in mNSCLC
WCLC 2022: Association between KRAS/STK11/KEAP1 mutations and outcomes in POSEIDON: Durvalumab ± tremelimumab +...
WCLC 2022: Sexual dysfunction high among women with lung cancer
WCLC 2022: Sexual dysfunction high among women with lung cancer
WCLC 2022: Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for patients with unresectable stage III NSCLC
WCLC 2022: Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for...
Why do men face a higher risk of most types of cancer than women?
Why do men face a higher risk of most types of cancer than women?
Budget impact analysis demonstrates NELSON screening model would save more than 18,000 premature lung cancer deaths
Budget impact analysis demonstrates NELSON screening model would save more than 18,000 premature lung cancer deaths
WCLC 2022: Phase II study of durvalumab plus concurrent radiotherapy in unresectable locally advanced NSCLC: DOLPHIN Study
WCLC 2022: Phase II study of durvalumab plus concurrent radiotherapy in unresectable locally advanced NSCLC:...
WCLC 2022: Sub-lobar surgery for peripheral non-small cell lung cancer non-inferior to lobectomy
WCLC 2022: Sub-lobar surgery for peripheral non-small cell lung cancer non-inferior to lobectomy
WCLC 2022: IMPower010: Overall survival interim analysis of a phase III study of atezolizumab vs best supportive care in resected NSCLC
WCLC 2022: IMPower010: Overall survival interim analysis of a phase III study of atezolizumab vs best supportive...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation